Is Fagron N.V. (FAGR.BR) a Buy, Sell, or Hold?
BRU : FAGR.BR
Fagron N.V.
$23.2 EUR
-$0.55 (-2.32%)
- Volume
- 155.14K
- Average Volume
- 88.03K
- Market Capitalization
- $1.7B
- P/E Ratio
- 18.56
- Dividend Yield
- 1.72%
- Price Target
- Year High
- $25.30
- Year Low
- $19.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.40
- Current Ratio
- $1.77
Company Overview
BRU
Rafael Padilla
Drug Manufacturers - Specialty & Generic
Healthcare
FAGR.BR
3828
BE
EUR
Liquidity Metrics
1.07
1.77
1.02
0.47
0.40
Sales & Valuation
$952.17M
1.65
2.86
14.34
1.62
Profitability
$1.24
$91.02M
8.92%
11.33%
16.01%
6.01%
P/E Metrics
18.56
2.71
2.71
Analyst Price Target & Rating
4/5
0 Analysts
%
Financial Health Scores
3.51
7/9
$216.19M
$1.53B
$925.69M
$289.75M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Karin de Jong | Chief Financial Officer & Executive Director |
| Vera Bakker | Chief Operating Officer |
| Ignacio Artola | Global Head of Investor Relations |
| Rafael Padilla | Chief Executive Officer & Executive Director |
Poll Results
No votes yet today — be the first to share your view!
About Fagron N.V. (BRU:FAGR.BR) Stock
Fagron N.V. operates as a pharmaceutical compounding enterprise, dedicated to providing customized medicinal solutions for hospitals, pharmacies, clinics, and individual patients. The company is actively involved in developing innovative concepts, delivery systems, and formulations within the compounding sector. Its extensive offerings encompass essential raw materials, specialized equipment, semi-finished products, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Additionally, through the Fagron Academy, the firm delivers educational and training programs to healthcare prescribers and pharmacists. With a significant global footprint, Fagron conducts operations across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and ... headquartered in Nazareth, Belgium, the company adopted its current name, Fagron NV, in January 2015, having previously been known as Arseus NV.
Frequently Asked Questions
-
What is the current Fagron N.V. (FAGR.BR) stock price?
-
Fagron N.V.(BRU:FAGR.BR) stock price is $23.2 in the last trading session. During the trading session, FAGR.BR stock reached the peak price of $25.3 while $19.24 was the lowest point it dropped to. The percentage change in FAGR.BR stock occurred in the recent session was --2.32% while the dollar amount for the price change in FAGR.BR stock was -$0.55.
-
FAGR.BR's industry and sector of operation?
-
The BRU listed FAGR.BR is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of FAGR.BR?
-
Karin de Jong | Chief Financial Officer & Executive Director
Vera Bakker | Chief Operating Officer
Ignacio Artola | Global Head of Investor Relations
Rafael Padilla | Chief Executive Officer & Executive Director
| -
How many employees does FAGR.BR have?
-
Number of FAGR.BR employees currently stands at 3828. FAGR.BR operates from Venecoweg 20A, Nazareth, VL 9810, BE.
-
Link for FAGR.BR official website?
-
Official Website of FAGR.BR is: https://www.fagron.com
-
How do I contact FAGR.BR?
-
FAGR.BR could be contacted at phone #32 8 001 28 80 and can also be accessed through its website. FAGR.BR operates from Venecoweg 20A, Nazareth, VL 9810, BE.
-
How many shares of FAGR.BR are traded daily?
-
The average number of FAGR.BR shares traded daily for last 3 months was 88.03K.
-
What is the market cap of FAGR.BR currently?
-
The market value of FAGR.BR currently stands at $1.7B with its latest stock price at $23.2